What Are the Challenges in Delivering RNAi Therapeutics?
One of the major hurdles in RNAi therapeutics is the effective delivery of siRNAs into target cells. siRNAs are vulnerable to degradation by nucleases in the bloodstream and have difficulty crossing cellular membranes. This is where nanotechnology comes into play, offering innovative solutions to enhance the stability and delivery of siRNAs.
